Turn Therapeutics
Turn Therapeutics is a pharmaceutical and medical device company focused on advanced wound and dermatologic care. Founded by Bradley Burnam, the company aims to invent better ways to treat disease with responsibility, safety, and efficacy. Their innovative platform technology and flagship formula have shown remarkable efficacy for a variety of indications, including eczema and onychomycosis. They leverage patented technology, multiple FDA clearances, and have over 200,000 uses of their products. The company is committed to transforming skin and wound care, emphasizing safety, patient education, and global market potential.
Industries
Nr. of Employees
small (1-50)
Turn Therapeutics
Calabasas, California, United States, North America
Products
Petrolatum-based antimicrobial topical dressing (prescription)
A petrolatum-based topical dressing formulated with antimicrobial actives for management of acute and chronic wounds and certain dermatologic conditions; intended for use under healthcare professional supervision.
Petrolatum-based antimicrobial topical dressing (prescription)
A petrolatum-based topical dressing formulated with antimicrobial actives for management of acute and chronic wounds and certain dermatologic conditions; intended for use under healthcare professional supervision.
Services
Licensing and distribution partnerships
Establishing in-licensing and distribution agreements to expand commercial availability of topical wound and dermatology products.
Licensing and distribution partnerships
Establishing in-licensing and distribution agreements to expand commercial availability of topical wound and dermatology products.
Expertise Areas
- Topical drug development
- Wound care and dermatology therapeutics
- Clinical trial design and execution
- Biomarker and cytokine assessment
Key Technologies
- Topical oil-based delivery
- Petrolatum-based formulations
- Polyhexamethylene biguanide (PHMB) antimicrobial chemistry
- Quaternary ammonium antiseptic agents